Litcius/Paper detail

1314MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Luis Paz‐Ares, M-J. Ahn, Aaron Lisberg, Satoru Kitazono, B.C. Cho, George R. Blumenschein, Elaine Shum, E. Pons-Tostivint, Yasushi Goto, Kiyotaka Yoh, Rebecca S. Heist, P. Baas, David Planchard, M. Pérol, Enriqueta Felip, Wu‐Chou Su, H. Zebger-Gong, Lei Lan, C. Liu, Jacob Sands

2023Annals of Oncology50 citationsDOI

Topics & Concepts

MedicineOncologyCancer researchLung cancerInternal medicineCancerLungLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research Studies
1314MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs) | Litcius